A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania

Keyphrases

• Acid Concentration 11%
• Acute Mania 11%
• Acute Treatment 100%
• Adverse Event Rates 11%
• Back Pain 11%
• Bipolar I Disorder 11%
• Change from Baseline 22%
• Change Score 11%
• Constipation 11%
• Daily Dose 11%
• Divalproex 77%
• Divalproex Sodium 100%
• DSM-IV 11%
• Extended Release 100%
• Final Evaluation 11%
• Mania 100%
• Mania Symptoms 22%
• Methodological Considerations 11%
• Negative Findings 11%
• Optimal Dosing 11%
• Placebo 66%
• Randomized Placebo-controlled Trial 100%
• Rating Scales 22%
• Release Treatment 11%
• Trial Registration 11%
• United States 11%
• Valproic Acid 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 11%
• Bipolar I Disorder 11%
• Constipation 11%
• Controlled Clinical Trial 11%
• DSM-IV 11%
• Placebo 100%
• Sodium Valproate 11%
• Valproate Semisodium 100%

Psychology

• I-Disorder 50%
• Mania Rating Scale 100%
• Methodological Consideration 50%